Key takeaways For costly medications, prior authorization (PA) is a common requirement
Further, because the only large-scale trials of GLP-1 agonists have been conducted in obese or overweight study populations, we dont yet know if these drugs affect body composition in normal-weight individuals in an equivalent manner
For bulk inquiries, private labeling, or export opportunities, connect with JoinHub Pharma today at [email protected] strategic manufacturing and supply partner in India.
Last year, obesity and diabetes drug sales totalled nearly 25 billion and has led Ozempic manufacturer Novo Nordisk to become Europes most valuable company with a market value of over $500 billion
How Generic Competition Will Impact Pricing According to pharmaceutical pricing research from the University of Toronto, when generic versions become available and competition increases: With one generic : Prices could drop to approximately 75% of the current list price With two generics : Prices could fall to 50% of the current list price With three or more generics : Prices could plummet to as low as 35% of the current price, potentially dropping from $540 to $100$150 per month This represents a potential 75% cost reduction, making Wegovy far more accessible to Canadians currently unable to afford it
Lipid droplet and its implication in cancer progression